Bita Geramizadeh, Sara Nabavizadeh, Alireza Rezvani, Nadereh Shamsolvaezin, Alireza Zahedinassab, Neda Khodadadi, Pouya Iranpour. Mast Cell Sarcoma of Small Intestine, Early Diagnosis, and Good Prognosis: An Extremely Rare Case Report and Review of the Literature.Gastrointestinal tumors. 2023, 10 (1): 1-5
Vijay W Dhakre, Sneha Tukaram Galande, Varsha Gunvant Patil, Nikita C Shah, Chetan Rathod, Kaiumarz S Sethna, Anjali D Amrapurkar. Mixed Neuroendocrine and Non-Neuroendocrine Neoplasm of Pancreas: What Do We Know, What Have We Learnt?Gastrointestinal tumors. 2023, 10 (1): 14-18
Adel Shahnam, Udit Nindra, Nicholas McNamee, Robert Yoon, Ray Asghari, Weng Ng, Deme Karikios, Mark Wong. Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric Cancers.Gastrointestinal tumors. 2023, 10 (1): 19-28
Tane Kim, Danny Issa, Mykola Onyshchenko. Analyzing TCGA Data to Identify Gene Mutations Linked to Hepatocellular Carcinoma in Asians.Gastrointestinal tumors. 2022, 9 (2-4): 43-58
Yugo Suzuki, Takayuki Okamura, Akira Matsui, Junnosuke Hayasaka, Kosuke Nomura, Daisuke Kikuchi, Shu Hoteya. Usefulness of the Japan Esophageal Society Classification of Barrett's Esophagus for Diagnosing the Lateral Extent of Superficial Short-Segment Barrett's Esophageal Cancer.Gastrointestinal tumors. 2022, 9 (2-4): 59-68
Vijay W Dhakre, Shrikant S Suryawanshi, Vijay P Shewale, Chetan Rathod, Sneha Tukaram Galande, Kaiumarz S Sethna. Successful Use of Direct Splenic Vein Anastomosis to the Interposition Internal Jugular Vein Graft after Extended Pancreatoduodenectomy to Avoid Sinistral Portal Hypertension.Gastrointestinal tumors. 2022, 9 (2-4): 69-73
Davide Lanza, Adrian Casty, Stefan H Schlosser. Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction over 32-Month Follow-Up.Gastrointestinal tumors. 2022, 9 (1): 12-18
Timothy J Brown, Arjun Gupta, Ramy Sedhom, Muhammad S Beg, Thomas B Karasic, Mark Yarchoan. Trends of Clinical Outcomes of Patients with Advanced Hepatocellular Carcinoma Treated with First-Line Sorafenib in Randomized Controlled Trials.Gastrointestinal tumors. 2022, 9 (1): 19-26
Linda Skibsted Kornerup, Frederik Kraglund, Ulla Feldt-Rasmussen, Peter Jepsen, Hendrik Vilstrup. Thyroid Disease and Hepatocellular Carcinoma Survival: A Danish Nationwide Cohort Study.Gastrointestinal tumors. 2022, 9 (1): 37-42
Vijay Waman Dhakre, Govind Purushothaman, Nilesh Doctor. Gallbladder Neuroendocrine Tumors: Is There a Need for a Specific Approach?Gastrointestinal tumors. 2022, 9 (1): 5-11
Maher Hendi, Yiping Mou, Jiemin Lv, Bin Zhang, Xiujun Cai. Hepatic Arterial Infusion Chemotherapy Is a Feasible Treatment Option for Hepatocellular Carcinoma: A New Update.Gastrointestinal tumors. 2021, 8 (4): 145-152